Werfen companies now under one name, brand

July 15, 2021—Werfen announced that its companies, including Instrumentation Laboratory, Inova Diagnostics, and Biokit, are uniting under one name and one brand—Werfen—and a new corporate logo.

“This transformation represents a natural evolution for Werfen, strengthening our global leadership position in specialized diagnostics and positively impacting our ability to drive innovation and support our customers,” Carlos Pascual, CEO at Werfen, said in a press statement. “By sharing one global identity, with the same vision and strategic objectives, our teams around the world will maximize collaboration to set new standards for products and services in hemostasis, acute care, autoimmunity, and OEM diagnostics.”

The hubs for the company’s key business lines will be led by chief operating officers and operate as Werfen headquarters and technology centers. These include hemostasis and acute care diagnostics in Bedford, Mass., autoimmunity in San Diego, and original equipment manufacturing in Barcelona, Spain. Additional technology centers are based in Orangeburg, NY, San Diego, and Munich.

Management and organization of Werfen’s commercial operations in North America will be consolidated, covering hemostasis, acute care, and autoimmunity, based in Bedford, and led by senior VP, Brian P. Durkin. Field service and customer service functions will be unified across business lines, and sales, applications, marketing, and technical support will remain specialized.

Werfen has direct commercial operations in more than 30 countries and employs 5,500 people.